饮食和运动对儿童肥胖相关的血管功能障碍的影响
Kam S Woo1, Ping Chook, Chung W Yu
1Department of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong. kamsangwoo@cuhk.edu.hk
Circulation
|April 7, 2004
概括
儿童肥胖导致动脉功能障碍. 饮食和运动干预可以扭转这种血管功能障碍,饮食和运动的结合显示出儿童血管健康的最佳结果.
科学领域:
- 儿科心脏病学 儿科心脏病学
- 血管生物学 血管生物学
- 预防医学 预防医学
背景情况:
- 儿童肥胖是一个日益蔓延的流行病.
- 儿童肥胖与早期的动脉功能障碍和动脉变厚有关.
- 这些血管变化是动脉样硬化的前体.
研究的目的:
- 评估生活方式干预是否可以逆转与肥胖相关的动脉功能障碍和儿童的动脉内心介质厚化.
- 为了比较单独饮食与饮食加运动的有效性.
主要方法:
- 82名超重儿童 (9-12岁) 被随机分为仅饮食或饮食加监督运动6周,随后是1年.
- 通过超声波测量的主要结局是手臂动脉内皮功能和动脉内膜介质厚度.
- 其次性结局包括腰比,胆固醇和身体脂肪含量.
主要成果:
- 这两种干预措施都改善了内皮功能,降低了腰比,并在6周后降低了胆固醇.
- 饮食加运动比单独饮食更能改善内皮功能.
- 在1年后,在继续炼的儿童中,观察到血管健康和身体组成的持续改善.
结论:
- 儿童中与肥胖相关的血管功能障碍是可逆的,随着生活方式的改变.
- 组合饮食和运动干预措施特别有效.
- 持续坚持饮食和运动会导致儿童的长期血管健康益处.
相关概念视频
Hypertension and Regulation of Blood Pressure
3.8K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.8K
Obesity
1.5K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.5K
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
440
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
440
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
324
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
324
Hypertension II: Pathophysiology
1.8K
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
1.8K
Type II Diabetes II: Pathophysiology
28
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
28


